Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Artelo Biosciences ( (ARTL) ) just unveiled an update.
On January 30, 2026, Artelo Biosciences, Inc. entered into an Equity Purchase Agreement with Square Gate Capital Master Fund, LLC – Series 5, giving the company the right, but not the obligation, to sell up to $25 million of its common stock to Square Gate, with the capacity to increase the facility by an additional $25 million once the initial amount is fully used, in exchange for issuing 292,398 commitment shares valued at $500,000 and covering up to $35,000 of Square Gate’s due diligence and legal costs. The deal, which runs through January 30, 2029 unless earlier terminated, is structured as a private placement exempt from SEC registration and includes detailed volume, pricing, ownership, and exchange-cap limits on drawdowns, along with a Registration Rights Agreement obligating Artelo to register the resale of the shares, providing the company with a flexible, multiyear equity financing source while limiting immediate dilution and concentration of ownership for existing shareholders.
The most recent analyst rating on (ARTL) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on Artelo Biosciences stock, see the ARTL Stock Forecast page.
Spark’s Take on ARTL Stock
According to Spark, TipRanks’ AI Analyst, ARTL is a Neutral.
The score is primarily held down by very weak financial performance (no revenue, widening losses, ongoing cash burn) and heightened balance-sheet/listing risk (negative equity and Nasdaq compliance/delisting concerns). Technicals are only neutral-to-mixed and valuation offers limited support due to negative earnings and no dividend yield data.
To see Spark’s full report on ARTL stock, click here.
More about Artelo Biosciences
Artelo Biosciences, Inc. is a publicly traded company whose common stock is listed on a U.S. securities exchange and is actively traded, using equity financing arrangements as part of its capital-raising strategy.
Average Trading Volume: 538,632
Technical Sentiment Signal: Sell
Current Market Cap: $2.93M
See more insights into ARTL stock on TipRanks’ Stock Analysis page.